Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 5
1966 15
1967 9
1968 7
1969 5
1970 4
1971 24
1972 11
1973 8
1974 6
1975 20
1976 17
1977 21
1978 24
1979 18
1980 32
1981 10
1982 21
1983 13
1984 15
1985 18
1986 28
1987 16
1988 12
1989 21
1990 24
1991 24
1992 7
1993 5
1994 10
1995 29
1996 13
1997 19
1998 8
1999 24
2000 11
2001 24
2002 17
2003 17
2004 24
2005 19
2006 20
2007 21
2008 25
2009 26
2010 19
2011 24
2012 24
2013 23
2014 21
2015 14
2016 22
2017 14
2018 20
2019 16
2020 9
2021 14
2022 3
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

939 results

Results by year

Filters applied: . Clear all
Page 1
Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial.
Qian YY, Ru N, Chen H, Zou WB, Wu H, Pan J, Li B, Xin L, Guo JY, Tang XY, Hu LH, Jin ZD, Wang D, Du YQ, Wang LW, Li ZS, Liao Z. Qian YY, et al. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):238-244. doi: 10.1016/S2468-1253(21)00434-9. Epub 2022 Jan 25. Lancet Gastroenterol Hepatol. 2022. PMID: 35085482 Clinical Trial.
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relative risk 0.71, 95% CI 0.52-0.98; p=0.042). Transient adverse events occurred in 235 (34%) patients in the rectal indometacin group an …
Post-ESWL pancreatitis occurred in 60 (9%) patients in the rectal indometacin group and 84 (12%) patients in the placebo group (relat …
Other primary headaches-thunderclap-, cough-, exertional-, and sexual headache.
Bahra A. Bahra A. J Neurol. 2020 May;267(5):1554-1566. doi: 10.1007/s00415-020-09728-0. Epub 2020 Mar 4. J Neurol. 2020. PMID: 32130497 Free PMC article. Review.
These are a group of paroxysmal and precipitated headaches, which often occur in bouts with prolonged remissions. Indometacin seems to be the most effective preventative. Each can occur in primary and secondary form. ...
These are a group of paroxysmal and precipitated headaches, which often occur in bouts with prolonged remissions. Indometacin seems t …
Single dose oral indometacin for the treatment of acute postoperative pain.
Mason L, Edwards J, Moore RA, McQuay HJ. Mason L, et al. Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004308. doi: 10.1002/14651858.CD004308.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495100 Free PMC article. Review.
When taken for chronic pain conditions, indometacin has been associated with a high incidence of adverse events. ...REVIEWERS' CONCLUSIONS: Conclusions about the clinical efficacy of indometacin for postoperative cannot be made until more trials are conducted for a …
When taken for chronic pain conditions, indometacin has been associated with a high incidence of adverse events. ...REVIEWERS' CONCLU …
Solubilization of indometacin.
El-Sabbagh H, Ghanem AH, Abdel-Alim HM. El-Sabbagh H, et al. Pharmazie. 1978 Aug;33(8):529-31. Pharmazie. 1978. PMID: 724785
Three methods were employed for the solubilization of indometacin as an example of antirheumatic drugs, employing:--Non-ionic surface-active agents such as Tween 80 and 40, Myrj 53 and Brij 99,--urea and sodium citrate--urea-indometacin coprecipitate. ...Urea-ind …
Three methods were employed for the solubilization of indometacin as an example of antirheumatic drugs, employing:--Non-ionic surface …
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL, Lehman GA, Tarnasky P, Cote GA, Schmidt SE, Waljee AK, Higgins PDR, Watkins JL, Sherman S, Kwon RSY, Elta GH, Easler JJ, Pleskow DK, Scheiman JM, El Hajj II, Guda NM, Gromski MA, McHenry L Jr, Arol S, Korsnes S, Suarez AL, Spitzer R, Miller M, Hofbauer M, Elmunzer BJ; US Cooperative for Outcomes Research in Endoscopy (USCORE). Fogel EL, et al. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):132-141. doi: 10.1016/S2468-1253(19)30337-1. Epub 2019 Nov 25. Lancet Gastroenterol Hepatol. 2020. PMID: 31780277 Free PMC article. Clinical Trial.
Clinically significant bleeding occurred in 14 (1%) of 1037 patients-six (1%) of 515 patients in the standard-dose indometacin group and eight (2%) of 522 patients in the high-dose indometacin group (p=0.79). ...A non-ST elevation myocardial infarction occurred in t …
Clinically significant bleeding occurred in 14 (1%) of 1037 patients-six (1%) of 515 patients in the standard-dose indometacin group …
Indometacin inhibits the proliferation and activation of human pancreatic stellate cells through the downregulation of COX-2.
Sun L, Chen K, Jiang Z, Chen X, Ma J, Ma Q, Duan W. Sun L, et al. Oncol Rep. 2018 May;39(5):2243-2251. doi: 10.3892/or.2018.6321. Epub 2018 Mar 16. Oncol Rep. 2018. PMID: 29565462
Treatment with indometacin suppressed the viability and the migration ability of PSCs in a dose-dependent manner. In addition, the immunoblotting and immunofluorescence results showed that alpha-SMA expression was markedly decreased by indometacin. A further study i …
Treatment with indometacin suppressed the viability and the migration ability of PSCs in a dose-dependent manner. In addition, the im …
The use of quantum chemistry in pharmaceutical research as illustrated by case studies of indometacin and carbamazepine.
Gordon KC, McGoverin CM, Strachan CJ, Rades T. Gordon KC, et al. J Pharm Pharmacol. 2007 Feb;59(2):271-7. doi: 10.1211/jpp.59.2.0013. J Pharm Pharmacol. 2007. PMID: 17270080 Review.
A brief introduction to quantum methods is provided and the use of these methods in understanding the structure and properties of indometacin and carbamazepine is discussed. The use of calculated structures and molecular electrostatic potentials in developing quantitative …
A brief introduction to quantum methods is provided and the use of these methods in understanding the structure and properties of indomet …
Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells.
Han L, Peng B, Ma Q, Ma J, Li J, Li W, Duan W, Chen C, Liu J, Xu Q, Laporte K, Li Z, Wu E. Han L, et al. Curr Med Chem. 2013;20(33):4142-4152. doi: 10.2174/09298673113209990249. Curr Med Chem. 2013. PMID: 23992308 Free PMC article.
Indometacin, an inhibitor of cyclooxygenase-2 (COX-2), has been shown to exert anticancer effects in a variety of cancers. ...In conclusion, these results suggest that indometacin plays a key role in down-regulating HG-induced proliferation and invasion in PC cells. …
Indometacin, an inhibitor of cyclooxygenase-2 (COX-2), has been shown to exert anticancer effects in a variety of cancers. ...In conc …
Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials.
Lin TM, Chi JE, Chang CC, Kang YN. Lin TM, et al. J Pain Res. 2018 Dec 19;12:83-91. doi: 10.2147/JPR.S186004. eCollection 2019. J Pain Res. 2018. PMID: 30588082 Free PMC article.
BACKGROUND: Gout, a common medical condition that causes pain, can be treated by painkillers and anti-inflammatories. Indometacin and etoricoxib are two such drugs. However, no synthesized evidence exists comparing etoricoxib with indometacin in treating patients wi …
BACKGROUND: Gout, a common medical condition that causes pain, can be treated by painkillers and anti-inflammatories. Indometacin and …
939 results